Evidence map›Paper›PMID 35575973›Full record

ArticleInfectious diseases and therapy2022

Response to Gomez et al.'s Letter to the Editor Regarding: "Cost-Effectiveness of the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Versus Lower-Valent Alternatives in Filipino Infants".

Johnna Perdrizet, Emily Horn, Winniefer Nua, Judith Perez-Peralta, Jennifer Nailes, Jaime Santos, Anna Ong-Lim

Open access · goldAbstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Infectious diseases and therapy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 92% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 2 countries.

Johnna PerdrizetGlobal Health Economics and Outcomes Research, Pfizer Inc., 235 42nd Street, New York, NY, 10017, USA. johnna.perdrizet@pfizer.com.ORCID http://orcid.org/0000-0002-4260-7607
Emily HornGlobal Health Economics and Outcomes Research, Pfizer Inc., 235 42nd Street, New York, NY, 10017, USA.ORCID http://orcid.org/0000-0002-2491-7134
Winniefer NuaPfizer Inc., Makati City, Philippines.
Judith Perez-PeraltaPfizer Inc., Makati City, Philippines.
Jennifer NailesResearch Institute for the Health Sciences, University of the East Ramon Magsaysay Memorial Medical Center, Quezon City, Philippines.ORCID http://orcid.org/0000-0001-6334-0510
Jaime SantosInfectious Diseases Section, Philippine Children's Medical Center, Quezon City, Philippines.
Anna Ong-LimInfectious and Tropical Disease, Department of Pediatrics, College of Medicine-Philippine General Hospital, University of the Philippines, Manila, Philippines.
Makati Medical Center · PHPfizer (United States) · USPhilippine General Hospital · PHPhilippine Medical Association · PHUniversity of the East Ramon Magsaysay Memorial Medical Center · PH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Cost-effectivenessPneumococcal conjugate vaccineVaccines

Identifiers

PMID35575973
PMCPMC9334460
OpenAlexW4280530544

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.